发明名称 Utilización del 14,15-dihidro-20,21-dinoreburnamenin14-ol para tratar y/o prevenir las depresiones mayores
摘要 14,15-Dihydro-20,21-dinor-14-eburnameninol (I) is used to prepare a pharmaceutical composition for treating or preventing major depression or sleeping-waking cycle disorders. - 14,15-Dihydro-20,21-dinor-14-eburnameninol of formula (I), where the hydrogens at positions 3 and 16 are trans and the hydroxy group is in alpha or beta conformation, is used to prepare a pharmaceutical composition for treating or preventing major depression or sleeping-waking cycle disorders. - An INDEPENDENT CLAIM is also included for the use of (I) to prepare a pharmaceutical composition for treating patients with depression resistant to conventional antidepressants in order to make such patients sensitive to conventional antidepressant treatment. - ACTIVITY - Antidepressant. - MECHANISM OF ACTION - None given.
申请公布号 ES2430252(T3) 申请公布日期 2013.11.19
申请号 ES20050717501T 申请日期 2005.01.27
申请人 BIOCORTECH;MARCO POLO PHARMACEUTICALS 发明人 PUJOL, JEAN-FRANCOIS;WEISSMANN, DINAH
分类号 A61K31/4375;A61K9/16;A61K9/20;A61K9/48;A61K31/437;A61K31/4545;A61P25/24 主分类号 A61K31/4375
代理机构 代理人
主权项
地址